Search details
1.
Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.
Int J Cancer
; 138(3): 679-88, 2016 Feb 01.
Article
in English
| MEDLINE | ID: mdl-26311224
2.
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.
Cancer
; 118(7): 1946-54, 2012 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21882181
3.
Vascular endothelial growth factor polymorphisms: role in response and toxicity of tyrosine kinase inhibitors.
Curr Oncol Rep
; 12(2): 102-8, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20425594
4.
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
J Urol
; 180(3): 860-5; discussion 865-6, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18635227
5.
Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
Anticancer Res
; 26(3A): 1869-76, 2006.
Article
in English
| MEDLINE | ID: mdl-16827119
6.
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin.
Mol Cancer Ther
; 4(12): 1880-90, 2005 Dec.
Article
in English
| MEDLINE | ID: mdl-16373703
7.
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Oncogene
; 21(46): 7034-41, 2002 Oct 10.
Article
in English
| MEDLINE | ID: mdl-12370825
8.
Inhibition of NF-kappaB and proteasome activity in tumors: can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons.
Curr Pharm Des
; 8(22): 1945-58, 2002.
Article
in English
| MEDLINE | ID: mdl-12171521
9.
Differing von hippel lindau genotype in paired primary and metastatic tumors in patients with clear cell renal cell carcinoma.
Front Oncol
; 2: 51, 2012.
Article
in English
| MEDLINE | ID: mdl-22655276
10.
CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes.
Anticancer Res
; 30(12): 4791-8, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21187454
11.
Inhibition of proteasome activity by bortezomib in renal cancer cells is p53 dependent and VHL independent.
Anticancer Res
; 29(8): 2961-9, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19661301
Results
1 -
11
de 11
1
Next >
>>